2020 Annual Meeting | C244 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment

��ɫ��

2020 Annual Meeting | C244 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment

Date Thursday 04/30/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) David S. Knopman, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should develop an enhanced appreciation of the limits of sensitivity specificity of the diagnosis of Alzheimer's disease as an etiology of cognitive impairment.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, General Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:00 PM	Speaker	Clinical Diagnosis of Alzheimer Disease Richard J. Caselli, MD, FAAN
04:00 PM - 04:25 PM	Speaker	Biomarkers in the Diagnosis of Alzheimer Disease David S. Knopman, MD, FAAN
04:25 PM - 04:50 PM	Speaker	Clinical Genetics of Alzheimer Disease Richard J. Caselli, MD, FAAN
04:50 PM - 05:15 PM	Speaker	Status of Therapeutics in Alzheimer Disease David S. Knopman, MD, FAAN

Faculty Disclosures
Richard J. Caselli, MD, FAAN	The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.

��ɫ����

��ɫ����

��ɫ��

��ɫ��